Selling pressure pushes UiPath stock lower in today's trading

Traders Union
All News
Financial News
Uipath slides 3.76% today to $11.52

Highlights

UiPath is set to report Q4 results with revenue guidance of $462–$467 million, following Q3 growth of 15.9%.
Recent strategic moves include new Microsoft, Google, and NVIDIA partnerships, WorkFusion's acquisition, and healthcare automation launches to enhance AI compliance offerings.
The stock persists under selling pressure with bearish momentum, likely to consolidate between $11.38–$12.37, as technicals indicate a higher risk of further downside.

Growth outlook and partnerships advance amid persistent selling pressure

UiPath is scheduled to report its fourth-quarter fiscal 2026 results on March 11 after market close. In the third quarter, the company recorded revenue of $411 million, a 15.9% year-over-year increase, and has provided revenue guidance of $462 to $467 million for the fourth quarter. Recent developments include expanded automation platform capabilities through collaborations with Microsoft, Google, and NVIDIA, the launch of new healthcare automation services, and the acquisition of WorkFusion in February 2026 to bolster AI-driven compliance offerings. UiPath also achieved AIUC-1 certification for its AI agent safety and reliability, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, sees UiPath Inc. locked in a technical downtrend despite recent news about strategic partnerships and AI certifications. He observes that the rally above the MA-20 is not convincing, as momentum signals remain strongly bearish and volatility persists near recent lows. Kharitonov notes weak follow-through after positive revenue guidance, which points to market skepticism about sustaining growth. He is wary of the narrow trading range and warns that the downside risk is pronounced if $11.41 support fails. "Unless UiPath decisively reclaims the $13.50 mark, I remain skeptical of a meaningful reversal for now."

Viktoras Karapetjanc, expert at Traders Union, is constructive on UiPath’s outlook. He highlights significant revenue expansion and important deals with major tech firms as evidence of strengthening fundamentals. Karapetjanc believes the company’s AI leadership and WorkFusion acquisition bolster future competitiveness. He sees recent weakness as a technical pause within a broader bullish structure. "In my view, further growth is expected as the market absorbs new product launches and strategic milestones."

Mixed momentum and conflicting signals as downside pressure dominates

The nearest dynamic support is around the Ichimoku Kijun at $11.41, with MA-50 and $13.50 acting as key resistance. Momentum indicators show a mixed picture, with the daily MACD giving a strong sell signal and ADX also pointing to a bearish trend, suggesting falling momentum. RSI is neutral at 51, but Stoch RSI and BBP both signal overbought conditions, while CCI is positive but not extended. The AO does not lend clear directional support, and today’s session has seen the price drop 3.76% from the previous close, with only a narrow gap between sessions. Price currently trades near the lower end of today’s range after moderate intraday volatility, reflecting persistent downside pressure after the open. Given conflicting messages between some oscillators and primary momentum indicators, today’s intraday weakness mostly aligns with the prevailing negative momentum but highlights diverging short-term signals.

Previously it was reported that UiPath Inc. remained under sustained selling pressure, with the stock trading just above its short-term moving average but well below longer-term averages, reflecting ongoing bearish momentum. Key technical indicators, including MACD, ADX, and RSI, confirm a bearish trend, with resistance around the MA-50 and limited support until the kijun, while some overbought signals suggest recent buyer exhaustion amid continued volatility.

Source of Data: PATH Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.